Natalia K. Vereina

Natalia K. Vereina

Auto-generated profile, based on publicly available information

Natalia K. Vereina

South Ural State Medical University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2019 in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Verified
Journal Article
Open access
PDF file
OTO. A. Tarasova
O. A. Tarasova
SSS. P. Sinitsin
S. P. Sinitsin
NVN. K. Vereina
N. K. Vereina
VCVl. S. Chulkov
Vl. S. Chulkov
Objective.We performed a cross-sectional study of risk factors and biomarkers of cardiovascular diseases among young women with hypertensive disorders during pregnancy in comparison with women without hypertension during pregnancy.Design and methods.Altogether 117 women were enrolled, 33 were included in the group of hypertensive disorders during pregnancy, and 44 formed the group without hypertension during pregnancy. The control group consisted of 40 patients. The time interval after delivery was on average 5 to 19 years.Results and conclusions.Women with hypertension during pregnancy developed changes in carbohydrate and lipid metabolism associated with hypertension and abdominal obesity, which are the components of the cluster of the metabolic syndrome. These changes are also accompanied by insulin resistance, hyperinsulinemia, adipokine imbalance, changes in fbrinolysis and more pronounced remodeling of the heart and vessels as target organs in hypertension.

11 July 2020 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
TVT. V. Vavilova
T. V. Vavilova
LSL. V. Solovyova
L. V. Solovyova
ABA. B. Bekoeva
A. B. Bekoeva
PZP. Yu. Zubkova
P. Yu. Zubkova
NVN. A. Vorobyeva
N. A. Vorobyeva
ESE. V. Shlyakhto
E. V. Shlyakhto
Organization of anticoagulant therapy control plays a key role in ensuring the effectiveness and safety of anticoagulant use. Currently, several models of organization are successfully used in the Russian Federation, which cover more than 23000 patients at high risk for thromboembolic events. There are following common features of the models used: the maximum reduction in the time from the moment of international normalized ratio (INR) testing with a quick communication with a patient for the need to adjust the dose, the ability to sort patients depending on the degree of hypocoagulation and the risks of events with the creation of a personalized approach to treatment, the organization of a shared information space and maintaining a register of patients.

18 July 2022 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
OSO. A. Shumakova
O. A. Shumakova
NVN. K. Vereina
N. K. Vereina
VCVasilii Chulkov
Vasilii Chulkov
SSS. P. Sinitsyn
S. P. Sinitsyn
Modern professional education of internists is being updated at an intensive pace. This is primarily due to the fact that medicine and its technologies do not stand still, rushing into a high-tech future. In this regard, people have great hopes for highly effective conservative care, including for hematological diseases. Basic research on the mechanisms of blood clotting has greatly improved the knowledge of complex pathophysiology. These advances have led to a more complex decision-making process, which is reflected in the complex effect of hemostasis imbalance on the complement system, immunity and inflammation, and hence on the treatment of hemostasis disorders. Given this rapidly changing context, optimal educational activities are needed to disseminate knowledge among health professionals and develop their competencies in this field. Specialized professional associations can provide support and training offerings that facilitate access to relevant resources and tools to enable high-quality, up-todate basic and clinical research.

28 December 2014 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
VCVasilii Chulkov
Vasilii Chulkov
NVN. K. Vereina
N. K. Vereina
SSS. P. Sinitsyn
S. P. Sinitsyn
VDV. F. Dolgushina
V. F. Dolgushina
Цель. Оценить влияние достижения целевого артериального давления (АД) на течение и исходы беременности у беременных с артериальной гипертензией (АГ). Материал и методы. Исследование с проспективной когортой. В исследование включены 300 беременных; из них в группу I вошли 103 женщины с АГ, не достигших целевого АД; в группу II – 97 женщин с АГ, достигших целевого АД; в группу контроля – 100 женщин без АГ. Проводились клиническое обследование и наблюдение, анализ медицинской документации, стандартное лабораторно-инструментальное обследование, молекулярно-генетическое исследование методом полимеразной цепной реакции. Результаты. У женщин без достижения целевого АД беременность чаще осложнялась синдромом задержки развития плода и преэклампсией, а в исходе беременности чаще отмечались преждевременные роды и антенатальная гибель плода, у новорожденных в этой группе были более низкие весоростовые показатели, среди них чаще встречались маловесные дети; у них также отмечалась большая частота мутантного D-аллеля полиморфизма гена ACE (I/D) и мутантного С-аллеля полиморфизма гена рецептора 1 типа ангиотензина II (ATR11166 A/C) по сравнению с группой с достижением АД и контрольной группой. По результатам логистического регрессионного анализа факторами, независимо ассоциированными с совокупным неблагоприятным исходом, оказались преждевременные роды в анамнезе – увеличивают вероятность почти в 6 раз (ОШ=5,93; 95% ДИ 1,83-19,2; p=0,003), преэклампсия в данную беременность – увеличивает вероятность в 3,7 раз (ОШ=3,68; 95%ДИ 1,48-9,16; p=0,005), а достижение целевого АД (<140/90 мм рт.ст.) уменьшает вероятность совокупного неблагоприятного исхода – в 8 раз (ОШ=0,12; 95% ДИ 0,05-0,28; p<0,001). Заключение. Достижение целевого уровня АД у беременных с АГ может быть независимым фактором, влияющим на частоту акушерских осложнений и неблагоприятных исходов беременности. Определенный вклад в достижение целевых уровней АД у беременных с АГ вносят молекулярно-генетические полиморфизмы в генах ренин-ангиотензиновой системы.

27 July 2023 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
SGS. R. Gilyarevsky
S. R. Gilyarevsky
NVN. K. Vereina
N. K. Vereina
MGM. V. Golshmid
M. V. Golshmid
The article is devoted to the discussion of modern approaches to the use of laboratory methods to improve the tactics of using direct oral anticoagulants (DOACs) therapy. Clinical situations in which it may be reasonable to use data on the blood concentration of DOACs are given, including very old age, a marked deviation from the norm of body weight or impaired renal function. Data on the role of measuring the blood level of DOACs are considered in cases of the development of diseases or complications in which information is required on the preservation of the anticoagulant effect of DOACs, for example, in the development of severe bleeding or the need for urgent surgical intervention. The advantages and limitations of modern laboratory methods for assessing the blood concentration of DOACs are discussed. It is emphasized that one of the main advantages of using DOACs is the absence of the need to monitor laboratory parameters in most patients. Data from pharmacological studies are presented that may be useful in explaining the mechanisms that determine the higher safety of some DOACs compared to others. Promising methods for assessing the blood level of DOACs, as well as the possibility of using less specific reagents for assessing the concentration of DOACs, are considered. The possibility of using less specific, but more accessible methods for assessing the blood concentration of factor Xa inhibitors, in particular, a reagent for assessing the level of the antifactor, which is used to determine the blood level of heparin, is being considered. The opinions of experts on the role of assessing the blood level of DOACs and the possibility of tactics for selecting doses of DOACs based on laboratory analysis data are given.

3 December 2022 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
OSO. A. Shumakova
O. A. Shumakova
NVN. K. Vereina
N. K. Vereina
VCVasilii Chulkov
Vasilii Chulkov
EME. E. Minina
E. E. Minina
SSS. P. Sinitsin
S. P. Sinitsin
Modern teaching to young physicians has become increasingly limited because of rising clinical workload, due to the epidemiological situation, new requirements for medical documentation, the lack of a clear timetable of working hours and other educational features. Additionally, today’s residents expect that the training sessions will provide focused content integrated into their clinical workflow. One of the classical teaching methods that is ideally suited to meet these needs is a focused thematic training session, usually conducted with the help of simple but accessible visual aids and extensive audience participation. However, most listeners will benefit from structured content and guidance on the delivery of this content, also known as a learning scenario. A good learning scenario resident’s misconception, highlights a certain number of learning moments, uses strategies to engage students and provides a cognitive basis for teaching a topic that the teacher can improve over time. The proposed pedagogical concept of teaching sections of clinical hemostasiology for residents in the specialty "Therapy" orients the professional and cognitive interest of a young specialist against the background of constantly updated new knowledge in this field with the integration of scenarios of the content of training into clinical practice.